Abstract
Previously, we showed that extracts of ripe seasonal sweet corn tassels possess anti-irritant and anti-oxidant activities. The chemical identification of corn tassel bioactives was investigated by HPLC analysis. The hydroalcoholic extracts are composed primarily ( > 85%) phenolic-type compounds. The predominant component from C18 columns were concentrated by reverse phase chromatography and purified to greater than 97-99% by preparative HPLC chromatography. The chemical was determined by mass and NMR spectrometry to be 4-hydroxy-1-oxindole-3-acetic acid (Tasselin A) with a M.W of 207 daltons. Purified Tasselin A inhibits melanin production in sporulating cultures of the common bread mold. An anti-tyrosinase enzyme assay showed that it inhibits mushroom tyrosinase enzyme (IC50 = 0.75mM), and has both antioxidant, and skin anti-irritant activities. There are no prior reports of bioactives derived from corn tassels with potential skin whitening activity, nor are any corn tassel bioactivities currently employed as ingredients in personal care or skin care products.
Keywords: Anti-tyrosinase, bioactives, corn tassels, 4-hydroxy-2-oxindole-3-acetic acid, melanin inhibitor, skin whitener, HPLC, kojic acid, tasselin A, anti-irritant
Current Bioactive Compounds
Title: Bioactives Derived from Ripe Corn Tassels: A Possible New Natural Skin Whitener, 4-Hydroxy-1-Oxindole-3-Acetic Acid
Volume: 7 Issue: 2
Author(s): John J. Wille and Mark A. Berhow
Affiliation:
Keywords: Anti-tyrosinase, bioactives, corn tassels, 4-hydroxy-2-oxindole-3-acetic acid, melanin inhibitor, skin whitener, HPLC, kojic acid, tasselin A, anti-irritant
Abstract: Previously, we showed that extracts of ripe seasonal sweet corn tassels possess anti-irritant and anti-oxidant activities. The chemical identification of corn tassel bioactives was investigated by HPLC analysis. The hydroalcoholic extracts are composed primarily ( > 85%) phenolic-type compounds. The predominant component from C18 columns were concentrated by reverse phase chromatography and purified to greater than 97-99% by preparative HPLC chromatography. The chemical was determined by mass and NMR spectrometry to be 4-hydroxy-1-oxindole-3-acetic acid (Tasselin A) with a M.W of 207 daltons. Purified Tasselin A inhibits melanin production in sporulating cultures of the common bread mold. An anti-tyrosinase enzyme assay showed that it inhibits mushroom tyrosinase enzyme (IC50 = 0.75mM), and has both antioxidant, and skin anti-irritant activities. There are no prior reports of bioactives derived from corn tassels with potential skin whitening activity, nor are any corn tassel bioactivities currently employed as ingredients in personal care or skin care products.
Export Options
About this article
Cite this article as:
J. Wille John and A. Berhow Mark, Bioactives Derived from Ripe Corn Tassels: A Possible New Natural Skin Whitener, 4-Hydroxy-1-Oxindole-3-Acetic Acid, Current Bioactive Compounds 2011; 7 (2) . https://dx.doi.org/10.2174/157340711796011115
DOI https://dx.doi.org/10.2174/157340711796011115 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Acyclovir in the Treatment of Herpes Viruses – A Review
Current Medicinal Chemistry Stem Cells in Brain Tumorigenesis and their Impact on Therapy
Current Stem Cell Research & Therapy Medicinal Properties of the Jamaican Pepper Plant Pimenta dioica and Allspice
Current Drug Targets Editorial (Thematic Issue: Medicinal Inorganic Chemistry: Identification of New Targets in Drug Discovery)
Current Topics in Medicinal Chemistry The Recombinant T Cell Receptor Strategy: Insights into Structure and Function of Recombinant Immunoreceptors on the Way Towards an Optimal Receptor Design for Cellular Immunotherapy
Current Gene Therapy NAD+ Metabolism and NAD+-Dependent Enzymes: Promising Therapeutic Targets for Neurological Diseases
Current Drug Targets Tachykinins and their Receptors in Human Malignancies
Current Drug Targets Novel Superactive Leptin Antagonists and their Potential Therapeutic Applications
Current Pharmaceutical Design Targeting Tumor Microenvironment with Silibinin: Promise and Potential for a Translational Cancer Chemopreventive Strategy
Current Cancer Drug Targets Biological and Chemical Aspects of Natural Biflavonoids from Plants: A Brief Review
Mini-Reviews in Medicinal Chemistry Flax Terpenoid Pathway as a Source of Health Promoting Compounds
Mini-Reviews in Medicinal Chemistry Inflammatory Markers in Coronary Artery Disease: Pathophysiological Mechanisms, Prognostic and Therapeutic Implications
Current Cardiology Reviews Adenovirus Vectors and Subviral Particles for Protein and Peptide Delivery
Current Gene Therapy Therapeutic Potential of Janus Kinase 3 (JAK3) Inhibitors
Current Pharmaceutical Design Resistance to Anti-VEGF Agents
Current Pharmaceutical Design Topoisomerases and Tubulin Inhibitors: A Promising Combination for Cancer Treatment
Current Medicinal Chemistry - Anti-Cancer Agents Near-Infrared Dyes: Probe Development and Applications in Optical Molecular Imaging
Current Organic Synthesis Polyethyleneimine-Based Nanocarriers for Gene Delivery
Current Pharmaceutical Design A Review on the Effects of Androgen Deprivation Therapy (ADT) on Bone Health Status in Men with Prostate Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Clinical Impact of Gene Expression Profiling on Oncology Diagnosis, Prognosis, and Treatment
Combinatorial Chemistry & High Throughput Screening